Halting Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Neuron-Inhibitory Liposomes
Source abstract
Abstract
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy. The occurrence of perineural invasion is associated with neuropathic pain and poor prognosis of PDAC, underscoring the active participation of nerves and their potential as therapeutic targets. Lidocaine is a local anesthetic with antitumor properties in some tumors in the clinic. Nevertheless, its clinical application in PDAC is constrained by the insufficient tumor accumulation and potential neurovirulence associated with a high-dose regimen. Here, a tumor microenvironment-targeted and -responsive liposome was constructed to deliver lidocaine for restraining PDAC growth through single nerve regulation. By conjugation of a collagen binding peptide, the pH-responsive liposomes accumulate in the extracellular matrix. The released lidocaine selectively reduces neurite length and density, thereby indirectly halting the progression and metastasis of PDAC in an orthotopic mouse model without noticeable adverse effects. This study highlights the potential of anesthetic-based nanomodulation of crosstalk between nerve and tumor cells for PDAC treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer, Stress, Anesthesia, and Immune Response · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences
Jilin University
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience
National Center for Nanoscience and Technology
College of Materials Science and Optoelectronic Technology
University of Chinese Academy of Sciences
Funding
National Key Research and Development Program of China · Natural Science Foundation of Beijing Municipality · China Academy of Chinese Medical Sciences
References (42)
Show source-provided references
1. 10.1136/bmj-2022-07399510.1136/bmj-2022-073995 ↗
2. 10.1038/nrc313110.1038/nrc3131 ↗
3. 10.1016/j.cell.2023.02.00210.1016/j.cell.2023.02.002 ↗
4. 10.1158/0008-5472.CAN-08-181010.1158/0008-5472.CAN-08-1810 ↗
5. 10.1016/j.ccell.2017.11.00710.1016/j.ccell.2017.11.007 ↗
6. 10.1158/2159-8290.CD-18-139810.1158/2159-8290.CD-18-1398 ↗
7. 10.1038/nrgastro.2015.16610.1038/nrgastro.2015.166 ↗
8. 10.1158/0008-5472.CAN-13-205010.1158/0008-5472.CAN-13-2050 ↗
9. 10.1053/j.gastro.2020.04.03710.1053/j.gastro.2020.04.037 ↗
10. 10.1073/pnas.151260311310.1073/pnas.1512603113 ↗
11. 10.1038/s41467-023-38128-x10.1038/s41467-023-38128-x ↗
12. Ketterer K. · Clin. Cancer Res. · 2003 · 9 · 5127
13. 10.1038/ncomms1513010.1038/ncomms15130 ↗
14. 10.1097/ALN.0b013e3181a913e110.1097/ALN.0b013e3181a913e1 ↗
15. 10.1016/j.tcm.2010.03.00210.1016/j.tcm.2010.03.002 ↗
16. 10.3389/fonc.2021.66974610.3389/fonc.2021.669746 ↗
17. 10.3389/fphar.2022.77089210.3389/fphar.2022.770892 ↗
18. 10.1016/j.celrep.2023.11343710.1016/j.celrep.2023.113437 ↗
19. 10.1016/j.bja.2020.03.03410.1016/j.bja.2020.03.034 ↗
20. 10.1016/j.bja.2022.03.03110.1016/j.bja.2022.03.031 ↗
21. 10.3390/jcm1112354310.3390/jcm11123543 ↗
22. 10.3748/wjg.v27.i18.210510.3748/wjg.v27.i18.2105 ↗
23. 10.1186/s13045-017-0448-510.1186/s13045-017-0448-5 ↗
24. 10.1073/pnas.190862611610.1073/pnas.1908626116 ↗
25. 10.1016/j.biomaterials.2022.12194510.1016/j.biomaterials.2022.121945 ↗
26. 10.1016/j.nantod.2023.10199310.1016/j.nantod.2023.101993 ↗
27. 10.1016/j.nantod.2022.10153310.1016/j.nantod.2022.101533 ↗
28. 10.1038/s41467-018-05906-x10.1038/s41467-018-05906-x ↗
29. 10.1021/acsnano.0c0886010.1021/acsnano.0c08860 ↗
30. 10.1093/rb/rbad04510.1093/rb/rbad045 ↗
31. 10.3109/10717544.2014.88246910.3109/10717544.2014.882469 ↗
32. 10.1016/j.ajps.2017.05.00810.1016/j.ajps.2017.05.008 ↗
33. 10.1016/j.jconrel.2015.12.00610.1016/j.jconrel.2015.12.006 ↗
34. 10.1016/0378-5173(93)90389-W10.1016/0378-5173(93)90389-W ↗
35. 10.1073/pnas.090336910610.1073/pnas.0903369106 ↗
36. 10.1016/j.nantod.2023.10181410.1016/j.nantod.2023.101814 ↗
37. 10.1038/nrc.2016.3810.1038/nrc.2016.38 ↗
38. 10.1126/sciadv.aay197110.1126/sciadv.aay1971 ↗
39. 10.1038/s41551-023-01019-z10.1038/s41551-023-01019-z ↗
40. 10.1007/s10853-022-07447-710.1007/s10853-022-07447-7 ↗
41. 10.1016/j.ejpb.2010.02.00710.1016/j.ejpb.2010.02.007 ↗
42. 10.1038/s41551-022-00909-y10.1038/s41551-022-00909-y ↗